PYC Therapeutics Ltd (PYC) — Capital Reinvestment Ratio

Latest as of June 2017: 0.00x

PYC Therapeutics Ltd (PYC) has a Capital Reinvestment Ratio of 0.00x as of June 2017, meaning it reinvests 0% of its operating cash flow (AU$1.73 Million) in capital expenditures (AU$608.00). Check PYC Therapeutics Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.73 Million
AUD

Capital Expenditures

AU$608.00
AUD

Data as of

Jun 2017
Most recent filing

PYC Therapeutics Ltd Capital Reinvestment Ratio (2004–2004)

This chart tracks PYC Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see PYC cash flow metrics.

Annual Capital Reinvestment Ratio for PYC Therapeutics Ltd (2004–2004)

Year-by-year Capital Reinvestment Ratio for PYC Therapeutics Ltd from 2004 to 2004. See PYC Therapeutics Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2004 0.11x AU$28.00K AU$3.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow